Search results
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
Gannett via AOL· 13 hours agoThat St. Louis-based law firm was the only bidder to respond to the RFP. Prospective...originally...
New Weight-Loss Drugs and Devices Are Coming This Week
Barrons.com· 10 hours agoWeight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American...
Gateway - Quartz
Quartz· 5 hours agoThe world’s largest company for diabetes treatments alleges illegal marketing and sales practices by third-parties “created a high risk of consumer confusion and deception ...
‘Drug lady’ checks out of Jackson County schools and into retirement
WILX 10 Lansing· 7 hours agoSchool is out for the summer across mid-Michigan, and when the new school year starts in the fall...
New Havas Unit Focused On Opportunities Posed By GLP-1 Drugs
MediaPost· 5 hours agoHavas is using Cannes to announce the launch of a new consultancy that will develop client strategies surrounding increasingly popular GLP-1 medications like Ozempic that are used to treat diabetes ...
The twisty, titillating, controversial history of gay sex drug poppers
USA Today· 5 days agoPoppers as a gay sex drug dates back to the 1960s in the U.S. People joke that you can smell the...
Collaborative Drug Discovery (CDD) Includes Industry-Leading IUPAC Naming Technologies From...
Digital Journal· 16 hours agoView the original press release on newswire.com. View the original press release on accesswire.com ACCESSWIRE...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 14 hours agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Merit Medical recalls plastic syringes made by Jiangsu Shenli
MedTech Dive via Yahoo Finance· 19 hours agoThe recall affects kits that include unauthorized syringes manufactured by ...leak, break and...
Donanemab approval would fuel growth of amyloid-blocking Alzheimer’s drugs, analysts say
BioPharma Dive via Yahoo Finance· 7 days agoAt that meeting, expert FDA advisers voted 11-0 that donanemab’s benefits outweigh its risks,...